You are here: Welcome » pharmaceutical_companies » Qu Biologics

Menu

Rounding The Earth

Operation Uplift

Project List

Table of Contents

Qu Biologics

Qu Biologics, Inc. is a Canadian biotechnology company based in Burnaby, British Columbia.

History

Qu Biologics was founded in 2007 by Hal Gunn and Rob Freeman.1)

Organization

Qu Biologics is a member organization of the Biotechnology Innovation Organization (BIO) and N2 Canada.2) 3)

Personnel

Qu Biologicals - Team4) 5) 6) 7) 8)
Name Position Notes
Hal Gunn CEO and Founder InspireHealth, University of British Columbia (UBC)
Simon Sutcliffe Chief Medical Officer - Oncology Ontario Cancer Institute, Princess Margaret Hospital, BC Cancer Agency, Canadian Strategy for Cancer Control, Canadian Partnership Against Cancer, Canadian Cancer Society, National Medical Advisory Committee, Michael Smith Foundation for Health Research (MSFHR), Genome British Columbia, International Cancer Control Congress (ICCC), Two Worlds Cancer Collaboration, Premier Diagnostic Centre, Premier Diversified Holdings (PDH), InspireHealth, Institute for Health Systems Transformation & Sustainability (IHSTS), Terry Fox Research Institute (TFRI)
Ted Steiner Chief Medical Officer - Infectious Diseases University of British Columbia, Vancouver General Hospital (VGH), BC Children's Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Crohn's & Colitis Canada, Merck, COVID-19 Immunity Task Force (CITF), Vancouver Coastal Health Research Institute (VCHRI), COVID-19 Clinical Research Coordination Initiative (CRCI)
Matt Cahill Chief Operating Officer Deep Genomics, University of Toronto
Shirin Kalyan Vice President, Scientific Innovation Alexander von Humboldt Foundation, University of British Columbia
David Mullins Chief Scientific Officer (former) Norris Cotton Cancer Center, Society for the Biological Therapy of Cancer, American Association of Immunologists
Gillian Vandermeirsch Vice President of Operations (former) Pasteur Institute, Augurex, University of British Columbia
Bob Cory Vice President of Business Development (former) Bioasis Technologies, MIGENIX, Illumigen Biosciences
Julie Jang Director of Communications (former) Sirona Biochem, Zalicus, CityNews 1130, Global Television Network, CTV
Heidi Biagi Director of Project Management (former) Novadeq Technologies, QLT
Russell McAllister Vice President of Finance (former) Lakewood-Amedex, H.C. Wainwright & Co., Thomas Weisel Partners, Merriman Curhan Ford & Co., PricewaterhouseCoopers
Jim Pankovich Vice President of Clinical Operations & Drug Development (former) CIHR Canadian HIV Trials Network (CTN), MIGENIX, Inex Pharmaceuticals, CV Technologies
Kevin Harper Acting Director of Manufacturing (former) HH Consultancy, Sanofi Pasteur, Novartis
Nicole Clendinning Director of Finance (former) Chartered Professional Accountant of British Columbia
Alun Rees Vice President of Manufacturing (former) STEMCELL Technologies, QLT, GlaxoSmithKline, Bio Products Laboratories (BPL)
Mark Bazett (former) Director of Preclinical and Translational Research Meakins-Christie Laboratories
Board of Directors9)
Julia Levy Board member QLT, Foundation Fighting Blindness, Wilmer Eye Institute, Life Sciences British Columbia, University of British Columbia
Karn Manhas Board member Terramera, Young Presidents' Organization (YPO), Unreasonable Group
Mile Leschuk Board member Leschuk-Weisz Developments, Rob Freeman Foundation, PricewaterhouseCoopers, London Telecom Group
Foster Coulson Board member Integro Cap
Marc Lambiotte Board member West Coast General Hospital
Scientific Advisory Board10)
Dieter Kabelitz Scientific Advisor University of Kiel, German Society of Immunology, International Union of Immunological Societies, Rockefeller University, University of Heidelberg, Paul Ehrlich Institute, SFB 1315, Cluster of Excellence Inflammation at Interfaces
Bruce Vallance Scientific Advisor Child & Family Research Institute (CFRI), Crohn’s and Colitis Canada, CH.I.L.D. Foundation, BC Children's Hospital, University of British Columbia (UBC)
Balfour Sartor Scientific Advisor University of North Carolina at Chapel Hill, National Gnotobiotic Rodent Resource Center, Crohn's & Colitis Foundation
Michael Noble Scientific Advisor University of British Columbia
Robert E.W. Hancock Scientific Advisor University of British Columbia, R.E.W. Hancock Laboratory, MIGENIX, Inimex Pharmaceuticals, ABT Innovations, Sepset Biotherapeutics, Centre for Drug Research and Development (CDRD)
IBD Clinical Advisors11)
Brian Feagan Clinical Advisor Schulich School of Medicine & Dentistry, London Health Sciences Centre, Robarts Research Institute
William Sandborn Clinical Advisor University of California San Diego, UC San Diego Health System, Mayo Clinic
Brian Bressler Clinical Advisor University of British Columbia, Massachusetts General Hospital, Harvard Medical School
John Marshall Clinical Advisor McMaster University, Hamilton Health Sciences, Farncombe Family Digestive Health Research Institute, Canadian Association of Gastroenterology, American Gastroenterological Association

Funding

Since 2007, Qu Biologics has “raised over CAD$40 million in funding from private investors and government funding”.12)

The company has received grants and investment funding from:13) 14)

1) , 12)
Our History. Qu Biologics Inc. Retrieved May 1, 2023, from http://archive.today/2023.05.01-205011/https://www.qubiologics.com/who-we-are/our-history/
2)
BIO Member Directory. Biotechnology Innovation Organization. Retrieved September 30, 2022, from https://web.archive.org/web/20220930103715/https://www.bio.org/bio-member-directory
3)
Members. N2 Canada. Retrieved October 11, 2022, from http://archive.today/2022.10.11-054124/https://n2canada.ca/members/
4)
Management Team. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502003205/https://www.qubiologics.com/who-we-are/management-team/
5)
Management Team. Qu Biologics. Retrieved February 18, 2015, from http://archive.today/2015.02.18-140801/http://www.qubiologics.com/who-we-are/management-team/
6)
Management Team. Qu Biologics Inc. Retrieved October 1, 2016, from http://archive.today/2016.10.01-094757/http://www.qubiologics.com/who-we-are/management-team/
7)
Management Team. Qu Biologics. Retrieved April 15, 2017, from http://archive.today/2017.04.15-053456/http://www.qubiologics.com/who-we-are/management-team/
8)
Management Team. Qu Biologics. Retrieved April 19, 2018, from http://archive.today/2018.04.19-170653/http://www.qubiologics.com/who-we-are/management-team/
9)
Board of Directors. Qu Biologics Inc. Retrieved May 2, 2023, from https://web.archive.org/web/20230502044842/https://www.qubiologics.com/who-we-are/board-of-directors/
10)
Scientific Advisory Board. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507165939/https://www.qubiologics.com/who-we-are/scientific-advisory-board/
11)
IBD Clinical Advisors. Qu Biologics Inc. Retrieved May 7, 2023, from https://web.archive.org/web/20230507171856/https://www.qubiologics.com/who-we-are/clinical-advisors/
13)
Qu Biologics Inc. - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 1, 2023, from https://www.crunchbase.com/organization/qu-biologics-inc/company_financials
14)
Portfolio. ACA Group. Retrieved May 1, 2023, from http://archive.today/2023.05.01-212531/https://aca-investments.com/portfolio/
Back to top